Product
Dorzolamide-Timolol-Brimonidine + Latanoprost
Aliases
Dorzolamide-timolol-brimonidine and latanoprost, Gaap Ofteno PF®, Krytantek Ofteno PF®, PRO-122
Name
Dorzolamide Hydrochloride
INN Name
Dorzolamide
FDA Approved
Yes
1 clinical trial
2 organizations
3 indications
1 document
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionClinical trial
Phase IV Clinical Study to Compare the Efficacy of the Krytantek Ofteno PF® Plus Gaap Ofteno PF® Combination to the Krytantek Ofteno PF® Plus Gaap Ofteno PF® Combination, in Primary Open Angle Glaucoma or Ocular Hypertension Patients.Status: Terminated, Estimated PCD: 2023-11-23
Organization
Indoco Remedies Limited Organization
Biocon Pharma Inc.